This paper was to explore bullatacin-mediated multidrug-resistant cell apoptosis at extremely low concentration. To investigate its precise mechanisms, the pathway of cell apoptosis induced by bullatacin was examined. Bullatacin causes an upregulation of ROS and a downregulation of Δ m in a concentration-dependent manner in ABCB1-overexpressing KBv200 cells. In addition, cleavers of caspase-9, caspase-3, and PARP were observed following the release of cytochrome c from mitochondria after bullatacin treatment. However, neither cleavage of caspase-8 nor change of expression level of bcl-2, bax and Fas was observed by the same treatment. Pretreating KBv200 cells with N-acetylcysteine, an antioxidant modulator, resulted in a significant reduction of ROS generation and cell apoptosis induced by bullatacin. Bullatacin-induced apoptosis was antagonized by z-LEHD-fmk, a caspase-9 inhibitor, but not by z-IETD-fmk, a caspase-8 inhibitor. These implied that apoptosis of KBv200 cells induced by bullatacin was associated with the mitochondria-dependent pathway that was limited to activation of apical caspase-9. Copyright © 2009 Yong-Ju Liang et al.
CITATION STYLE
Fu, L. W., Liang, Y. J., Zhang, X., Dai, C. L., Zhang, J. Y., Yan, Y. Y., … Chen, L. M. (2009). Bullatacin triggered ABCB1-overexpressing cell apoptosis via the mitochondrial-dependent pathway. Journal of Biomedicine and Biotechnology, 2009. https://doi.org/10.1155/2009/867123
Mendeley helps you to discover research relevant for your work.